Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05166785 · ClinicalTrials.gov registry record · NA
BRInging the Diabetes Prevention Program to GEriatric Populations
A NA study of Pre Diabetes, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 238
- Enrollment target
- 1
- Study location
NCT05166785 is a NA study of Pre Diabetes that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 238 participants, below the 725-participant average among 59 other Pre Diabetes trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05166785, a NA study of Pre Diabetes, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
- 1
- Study location
Study Summary
Over 24 million Americans are over 65 years and have prediabetes. Prediabetes can be addressed using a public health approach: among the 20% of participants in the Diabetes Prevention Program (DPP) who were ages 60 and over, the diet and physical activity intervention conferred a 71% risk reduction of diabetes after an average follow-up of 3 years. The population of older adults is projected to more than double from 52.5 million in 2019 to \~100 million by 2060, and if projections hold, about half (48.3%) will have prediabetes. The proposed hybrid effectiveness implementation type 1 design will compare a DPP program Tailored for Older Adults and delivered via Telehealth (DPP-TOAT arm) to an in person DPP tailored for older adults (DPP arm) using a randomized, controlled trial design (n=230). The preliminary data suggests DPP-TOAT is a feasible and acceptable way to deliver the DPP to older adults, and this will be the first study to compare the effectiveness and implementation of two strategies (telehealth versus in-person) to deliver a tailored DPP for the unique needs of the growing population of older adults.
Conditions Studied
Interventions
- OTHER DPP Tailored for Older Adults and delivered via Telehealth
- OTHER In-Person Diabetes Prevention Program (DPP)
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2022-10-05 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05166785
The ClinicalTrials.gov registry entry for NCT05166785 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 725-participant average among 59 other Pre Diabetes trials with a reported enrollment target (67% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pre Diabetes appearing as the primary indexed condition, and to 2 interventions - of which DPP Tailored for Older Adults and delivered via Telehealth is the first listed.
NCT05166785 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05166785 about?
NCT05166785 is a clinical study titled "BRInging the Diabetes Prevention Program to GEriatric Populations". Over 24 million Americans are over 65 years and have prediabetes. Prediabetes can be addressed using a public health approach: among the 20% of participants in the Diabetes Prevention Program (DPP) who were ages 60 and over, the diet and physical activity intervention conferred a 71% risk reduction ...
What is the current status of trial NCT05166785?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 238 participants. The study started on 2022-10-05. Estimated completion is 2026-11.
What conditions does trial NCT05166785 study?
This clinical trial studies the following conditions: Pre Diabetes.
What interventions are being tested in trial NCT05166785?
The interventions under investigation include: DPP Tailored for Older Adults and delivered via Telehealth (OTHER), In-Person Diabetes Prevention Program (DPP) (OTHER).
Who is sponsoring clinical trial NCT05166785?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05166785 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pre Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals
RECRUITING · NA
-
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
RECRUITING · NA
-
Stand Up for Your Health with a Sit-stand Desk
RECRUITING · NA
-
Sisters of Heart (Hermanas de Corazón): A Community Health Worker Initiative for Improving Heart Health in Migrant Farmworker Women
RECRUITING · NA
-
Full Plate Living Nutrition Education Program
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.